Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to test the safety \& tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT07033494 · Early Alzheimer's Disease
NCT07531732 · Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease
NCT07290387 · Alzheimer Disease, Dementia, and more
NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more
Local Institution
Santa Ana, California
Local Institution
Hamden, Connecticut
Local Institution
Hialeah, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions